1 (609) 860-1300

About
DS & DP Capabilities
Technology Solutions
News & Events
Contact Us

搜索：

About J-STAR Research
cGMP Intermediate & API Production
- cGMP Quality Assurance
Contact Us
Delivering Small Molecules to the Clinic Faster – One Stop CMC
- J-STAR Research, Inc. Privacy Policy
DS & DP Capabilities
Resources
Resources: Search Results
Technology Solutions

Recent News

Porton Pharma and Aojin Life Sciences Form Strateg…
11 12 月, 2024
Porton Recognized for Sustainable Development in C…
6 12 月, 2024
Porton Pharma Solutions Launches Newly Redesigned …
6 12 月, 2024
Porton Attends China-Slovenia Business Forum and M…
13 11 月, 2024
Ceremony Marks Porton’s New Modality Capacit…
9 11 月, 2024

Upcoming Events

5 月 20

20 5 月 - 22 5 月

CPHI North America 2025

10 月 28

28 10 月 - 30 10 月

CPHI Europe 2025

About

About J-STAR Research
Facilities
Visitor Information
About Porton
Careers

Analytical R&D

Analytical R&D and Quality Control
Method Development & Forced Degradation
Method Validation & Verification
Reference Standard Certification
Impurity Isolation & Structural Elucidation
Genotoxic Impurities
ICH Stability Studies

Chemistry Process R&D

Process R&D/Drug Substance
Synthetic Route Design
High-Throughput Experimentation (HTE)
High Pressure Chemistry Capabilities
Continuous Flow Capabilities
Statistics & Design of Experiments (DoE)
Process Analytic Technologies (PAT) & Reaction Kinetics

Crystallization R&D

Crystallization R&D
Solid Form Screening & Selection
Single Crystal Structure Elucidation
Crystallization Process Development

Drug Product

Drug Product
Technology Demonstration and Feasibility
Pre-Formulation Evaluations
Phase 1 Clinical Supply and Support Services
Phase 2 & 3 Drug Product Development and Troubleshooting

Technology Solutions

Technology Solutions
Particle Engineering & Co-Processing
Computational Chemistry & Data Science Capabilities
- Predicting Molecular Properties via Computational Chemistry
- Computational Chemistry and Data Science Approaches for Pharmaceutical Development
Catalysis & Enabling Technology

High Potent & Controlled Substances

High Potent Compound & Controlled Substances
Controlled Substances (DEA Schedule II-V)
Potent & HPAPI Compound Development
ADC Payload & Linker

Resources

Brochures
Posters
Reports
Tech Bulletins
Videos
White Papers

Whitepapers

Molecular Modeling and Data Science for De-risking and Costsaving of Pharmaceutical Development

20 1 月, 2025

…

Blue outlined document icon with three lines of text on a curved white background. "Whitepaper" is written in orange below.

Enabling Technology II. Dry Particle Coating for the Enhancement of Flowability and Bulk Density

11 11 月, 2020

…

Blue outlined document icon with three lines of text on a curved white background. "Whitepaper" is written in orange below.

Enabling Technology I. Co-Precipitation Technology (CPT) for the Enhancement of Flowability and Bulk Density

11 11 月, 2020

…

About
DS & DP Capabilities
Technology Solutions
News

Become part of J-STAR's community to access personalized insights and resources.

By clicking "Submit" you agree to the terms & conditions set forth on the J-STAR Research Privacy Policy page.

ⓒ 2025 J-STAR Research, Inc., a subsidiary of Porton Pharma Solutions, Ltd. This website contains information intended for a broad audience and may include details or information which are not accessible or valid in your country. We accept no responsibility for information which may not comply with legal processes, regulations, registration, or usage in your country of origin.